Keywords: 246m, euros, ec/efpia, imi, drug, project, new
246M euros for EC/EFPIA's IMI drug R&D project
Article | 19 May 2009
15 new research projects aimed at bringing innovative medicines more quickly to the market have been selected to receive 246.0 million euros ($331.9 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
